Sedentary Behavior in African Americans (SeBA)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Robert Newton, Pennington Biomedical Research Center
ClinicalTrials.gov Identifier:
NCT00907465
First received: May 18, 2009
Last updated: December 2, 2012
Last verified: December 2012
  Purpose

The study is designed to develop methods for objectively measuring sedentary behavior, assess the association between objectively measured sedentary behavior and cardiovascular disease outcomes, and develop an intervention to reduce sedentary behavior, in African American adults.


Condition
Cardiovascular Disease

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Measurement of Sedentary Behavior in African American Adults

Further study details as provided by Pennington Biomedical Research Center:

Primary Outcome Measures:
  • Sedentary behavior [ Time Frame: 2009-2010 ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Blood pressure [ Time Frame: 2009-2010 ] [ Designated as safety issue: No ]
  • High density lipoproteins [ Time Frame: 2009-2010 ] [ Designated as safety issue: No ]

Enrollment: 25
Study Start Date: July 2007
Study Completion Date: October 2008
Primary Completion Date: October 2008 (Final data collection date for primary outcome measure)
Groups/Cohorts
Calibration study
These individuals were used to develop cut points for sedentary behavior using accelerometers and a metabolic chamber.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Community members of Baton Rouge, LA.

Criteria

Inclusion Criteria:

  • self-classify yourself as African American
  • are aged 18 years or older
  • are free of serious medical condition, such as cancer, cardiovascular disease, or emphysema.
  • are free of serious medical conditions that would prevent participant from engaging in physical activity.
  • are willing to have a scan completed that measures your body composition
  • are willing to stay in metabolic chamber for 8.5 hours (8:00am until 4:30 pm)
  • are willing to wear an accelerometer for 2, one-week periods following your chamber stay. There will be one week in-between the 2, one-week periods.
  • are willing to complete questionnaire related to your level of activity
  • weigh less than 250 lbs.

Exclusion Criteria:

  • unwilling or unable to perform activities in protocol
  • on medications
  • a woman who is intending to become pregnant, or who is pregnant
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00907465

Locations
United States, Louisiana
Pennington Biomedical Research Center
Baton Rouge, Louisiana, United States, 70808
Sponsors and Collaborators
Pennington Biomedical Research Center
Investigators
Principal Investigator: Robert L Newton, Ph.D. Pennington Biomedical Research Center
  More Information

No publications provided

Responsible Party: Robert Newton, Principal Investigator, Pennington Biomedical Research Center
ClinicalTrials.gov Identifier: NCT00907465     History of Changes
Other Study ID Numbers: PBRC 27013, 1K01HL088723-01
Study First Received: May 18, 2009
Last Updated: December 2, 2012
Health Authority: United States: National Institutes of Health

Additional relevant MeSH terms:
Cardiovascular Diseases

ClinicalTrials.gov processed this record on October 02, 2014